AI-Discovered Drug Enters Phase III Trials in China

A Chinese pharma company has advanced an AI-discovered lung disease drug into Phase III trials with 320 patients. The company is also investing $175 million in another AI-discovered drug.

2026-07-14 ~ 2026-07-14 · 2 related posts

• AI-Discovered Lung Disease Drug Enters Phase III Trials in China — 96Stats · 2026-07-14
• Chinese Pharma Advances AI-Discovered Drug to Phase III Trials — 96Stats · 2026-07-14